Allergan Plc Acquires RetroSense Therapeutics for $60,000,000

  • Feed Type
  • Date
  • Company Name
    RetroSense Therapeutics
  • Mailing Address
    330 East Liberty Street LL Ann Arbor, MI 48104 USA
  • Company Description
    Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel gene therapy approach to vision restoration.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under the terms of the transaction, Allergan has paid RetroSense a $60 million upfront payment, and has agreed to potential regulatory and commercialization milestone payments related to its lead development program, RST-001, a novel gene therapy for the potential treatment of Retinitis Pigmentosa (RP).

Trending on Xconomy